Download the comprehensive report now. Explore Clinical Stage Development and Strategic CollaborationsChange the industry! Lyme Disease Pipeline Outlook Report
Key Takeaways from the Lyme Disease Pipeline Report
December 2024、 Moderna TX Inc. We have started a Phase 1/2 randomized, observer-blinded, placebo-controlled, dose-ranging studyRateSafety and immunogenicity of Heptavalent mRNA-1975 (SR1-7) and monovalent mRNA-1982 (SR1) vaccines against Lyme disease in healthy elderly participants18-70 years old。
DelveInsight Lyme Disease Pipeline Report: Present Robust Landscape, and 7 or more active players. Development 7+ Pipeline Therapies for Treatment of Lyme Disease。
Lyme Disease Big Players include Valneva、Cortene、Blue Lake Biotechnology、Tarsus Pharmaceuticals、Inovio Pharmaceuticals、Aegis Life、Abzyme Therapeutics, And more.
Promising Lyme Disease Treatment. Like VLA15, mRNA-1975, low-dose TP-05, and others are in development.
Learn how leading Lyme disease companies are positioning themselves for success in the evolving pharmaceutical market.—Access the full report now! @ Evaluation of Lyme Disease Clinical Trials
Emerging Treatments for Lyme Disease
VLA15: Valneva
VLA15CurrentlyThe only active vaccine program in Clinical development against Lyme disease。
VLA15 is a Multivalent Recombinant Protein vaccine targeting six serotypes of Borrelia, representing the most common pathogenic strains United States and Europe。
Valneva has completed its recruitment and reported early recruitment results for two Phase 2 clinical trialsGet InvolvedOver 800 healthy adults, indicating High levels of antibodies everythingSix serotypes.
Valneva Announces Partnership with Pfizer for Late-Stage Development and Commercial Potential of VLA15.
CT38: Corten
CT38 is a Potent, short-lived peptide agonist selective for CRFR2, fully configured Naturally Occurring Amino Acids.
CT38 Tested on animals and Healthy humans in Phase 1 Clinical Trials, its definition Safety Profile for humans.
According to the study, CT38 only lasts in the body for a few hours.
The Lyme Disease Pipeline Report Offers the Following Insights:
Companies developing treatments for Lyme disease and Group therapy are developed by each company.
Various treatment candidates are classified as follows. Early, mid, and late development forthe Treatment of Lyme Disease。
Lyme Disease Companies Involved in Targeted drug development, including Active and inactive (dormant or discontinued) projects.
Treatment for Lyme disease development, categorized based on stage of development, route of administration, target receptor, monotherapy or combination therapy, mechanism of action, and type of molecule.
Detailed Analysis of Collaboration (company-to-company, company-to-academia)、 License Agreement, and Financing Details for Future Progress of Lyme Disease Market.
Don't miss out, download it now and stay up to date. @ Lyme disease medication
Lyme Disease Companies
Valneva, Cortene, Blue Lake Biotechnology, Tarsus Pharmaceuticals, Inovio Pharmaceuticals, Aegis Life, Abzyme Therapeutics, others.
The Lyme disease pipeline report provides treatment assessment (ROA) by route of administration.
Oral
Parenteral
Intravenous
Subcutaneous
Hot Topic
Lyme disease products categorized by molecular type:
Monoclonal antibodies
peptide
polymer
Low molecular weight
Gene Therapy
Stay up to date with insights into the latest Lyme disease pipeline. Download the report to take a closer look at next-generation treatments. @ Lyme Disease Market Drivers, Barriers, and Future Outlook
Lyme Disease Pipeline Report Scope
coverage: global
Lyme Disease Companies: Valneva、Cortene、Blue Lake Biotechnology、Tarsus Pharmaceuticals、Inovio Pharmaceuticals、Aegis Life、Abzyme Therapeutics など。
Lyme Disease Treatment: VLA15, mRNA-1975, low-dose TP-05, etc.
Lyme Disease Treatment Rating by Product Type: Mono, Combination, Mono/Combination
Lyme disease treatment assessment by clinical stage: Discovery, Preclinical, Phase I, Phase II, Phase III
Find the answers in our latest Lyme Disease Pipeline Insights report, which offers in-depth coverage of clinical trials, regulatory developments, and upcoming breakthroughs. Download it now and stay at the forefront of pharmaceutical innovation!" @Emerging Lyme Disease Drugs and Companies
table of contents
introduction
executive summary
Lyme Disease: An Overview
Pipeline Therapeutics
Therapeutic evaluation
Lyme Disease – A DelveInsight Perspective
Late Stage Products (Phase III)
VLA 15: Valneva
Drug profile in detailed report…..
Early Stage Products (Phase I)
CT 38: Corten
Drug profile in detailed report…..
Preclinical and Discovery Stage Products
Lyme Disease Vaccine - Introvacc
Drug profile in detailed report…..
Inactive Products
Lyme Disease Major Companies
Lyme Disease Main Products
Lyme Disease – An Unmet Need
Lyme Disease-Market Drivers and Barriers
Lyme Disease - Future Outlook and Conclusions
Lyme Disease Analyst's Viewpoint
Lyme Disease Major Companies
appendix
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm, providing clients with high-quality market intelligence and analytics to support informed business decisions. With an experienced team of industry experts and a deep understanding of the life sciences and healthcare sector, we deliver customized research solutions and insights to clients globally. Contact us to get high-quality, accurate, real-time intelligence to stay ahead of the growth curve.
Contact Information:
Himanshu
hmason@delveinsight.com
info@delveinsight.com
+14699457679
